Release Date: 02/05/23 08:12 Summary: Change of substantial holding from RMS Price Sensitive: No Download Document 97.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%